Is Histogen Stock a Good Investment?

Histogen Investment Advice

HSTO

To provide specific investment advice or recommendations on Histogen stock, we recommend investors consider the following general factors when evaluating Histogen. This will help you to make an informed decision on whether to include Histogen in one of your diversified portfolios:

Examine Histogen's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Histogen's leadership team and their track record. Good management can help Histogen navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Biotechnology space and any emerging trends that could impact Histogen's business and its evolving consumer preferences.
Compare Histogen's performance and market position to its competitors. Analyze how Histogen is positioned in terms of product offerings, innovation, and market share.
Check if Histogen pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Histogen's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Histogen stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Histogen is a good investment.

Sell

Buy

Strong Sell

We provide advice to complement the regular expert consensus on Histogen. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Histogen is not overpriced, please check out all Histogen fundamentals, including its net income and the relationship between the current ratio and total asset . As Histogen appears to be a penny stock we also urge to confirm its price to book numbers.

Market Performance	Very Weak	Details
Volatility	Out of control	Details
Hype Condition	Stale	Details
Current Valuation	Undervalued	Details
Odds Of Distress	Very High	Details
Economic Sensitivity	Moves totally opposite to the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Strong Buy	Details
Financial Strenth (F Score)	Frail	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unlikely Manipulator	Details

Examine Histogen Stock

Researching Histogen's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book (P/B) ratio of 0.02. Some equities with similar Price to Book (P/B) outperform the market in the long run. Histogen recorded a loss per share of 2.81. The entity last dividend was issued on the 27th of May 2020. The firm had 1:20 split on the 3rd of June 2022.

To determine if Histogen is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Histogen's research are outlined below:

	Histogen generated a negative expected return over the last 90 days
	Histogen has high historical volatility and very poor performance
	Histogen has some characteristics of a very speculative penny stock
	Histogen has a very high chance of going through financial distress in the upcoming years
	The company reported the previous year's revenue of 19 K. Net Loss for the year was (12.38 M) with loss before overhead, payroll, taxes, and interest of (1.25 M).
	Histogen currently holds about 12.6 M in cash with (10.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
	Histogen has a frail financial position based on the latest SEC disclosures

Histogen uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Histogen. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Histogen's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	9th of November 2023 Upcoming Quarterly Report	View
	30th of September 2023 Next Fiscal Quarter End	View
	30th of June 2023 Last Quarter Report	View

Earnings surprises can significantly impact Histogen's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Histogen's investors have experienced.

Reported	Fiscal Date	Estimated EPS	Reported EPS	Surprise
2023-03-09	2022-12-31	-0.79	-0.61	0.18	22
2022-11-10	2022-09-30	-1.26	-1.01	0.25	19
2023-11-09	2023-09-30	-0.54	-0.9	-0.36	66
2023-08-10	2023-06-30	-0.9	-0.49	0.41	45
2021-11-10	2021-09-30	-2.3	-1.8	0.5	21
2022-03-10	2021-12-31	-2.1	-1.4	0.7	33
2020-03-11	2019-12-31	-0.07	-0.8	-0.73	1042
2022-05-12	2022-03-31	-1.5	-0.2	1.3	86

Know Histogen's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Histogen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Histogen backward and forwards among themselves. Histogen's institutional investor refers to the entity that pools money to purchase Histogen's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.

			Shares
	Highlander Capital Management Llc	2024-03-31	17.0

Note, although Histogen's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Histogen's market capitalization trends

The company currently falls under 'Nano-Cap' category with a current market capitalization of 85.44 K.

Market Cap

2.91 Million

Histogen's profitablity analysis

	Last Reported	Projected for Next Year
Return On Tangible Assets	(0.64)	(0.67)
Return On Capital Employed	(0.69)	(0.72)
Return On Assets	(0.64)	(0.67)
Return On Equity	(0.85)	(0.89)

Determining Histogen's profitability involves analyzing its financial statements and using various financial metrics to determine if Histogen is a good buy. For example, gross profit margin measures Histogen's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Histogen's profitability and make more informed investment decisions.

Evaluate Histogen's management efficiency

Histogen has return on total asset (ROA) of (0.5381) % which means that it has lost $0.5381 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1989) %, meaning that it created substantial loss on money invested by shareholders. Histogen's management efficiency ratios could be used to measure how well Histogen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of November 2024, Return On Tangible Assets is likely to drop to -0.67. In addition to that, Return On Capital Employed is likely to drop to -0.72. At this time, Histogen's Total Assets are very stable compared to the past year. As of the 27th of November 2024, Non Current Assets Total is likely to grow to about 6.8 M, while Total Current Assets are likely to drop about 11.5 M.

	Last Reported	Projected for Next Year
Book Value Per Share	4.79	4.55
Tangible Book Value Per Share	4.79	4.55
Enterprise Value Over EBITDA	0.41	0.43
Price Book Value Ratio	0.21	0.20
Enterprise Value Multiple	0.41	0.43
Price Fair Value	0.21	0.20
Enterprise Value	-5.5 M	-5.3 M

Understanding the operational decisions made by Histogen management offers insights into its financial robustness. This evaluation is crucial for assessing the stock's investment potential.

Beta

1.118

Basic technical analysis of Histogen Stock

As of the 27th of November, Histogen retains the Risk Adjusted Performance of (0.07), market risk adjusted performance of 1.18, and Standard Deviation of 13.17. Histogen technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Histogen's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Histogen insiders, such as employees or executives, is commonly permitted as long as it does not rely on Histogen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Histogen insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Spada Alfred P over a year ago Acquisition by Spada Alfred P of 313436 shares of Histogen subject to Rule 16b-3
		Satz Brian over a year ago Acquisition by Satz Brian of 6835 shares of Histogen subject to Rule 16b-3
		Spada Alfred P over a year ago Acquisition by Spada Alfred P of 106793 shares of Histogen subject to Rule 16b-3
		Spada Alfred P over a year ago Histogen exotic insider transaction detected

Histogen's Outstanding Corporate Bonds

Histogen issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Histogen uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Histogen bonds can be classified according to their maturity, which is the date when Histogen has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Boeing Co 2196 Corp Bond US097023DG73	View
	HSBC Holdings PLC Corp Bond US404280DR76	View
	MGM Resorts International Corp Bond US552953CD18	View
	AerCap Global Aviation Corp Bond US00773HAA59	View

View All Histogen Corporate Bonds

Understand Histogen's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Histogen's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	(0.07)
	Market Risk Adjusted Performance	1.18
	Mean Deviation	4.52
	Coefficient Of Variation	(925.37)
	Standard Deviation	13.17
	Variance	173.49
	Information Ratio	(0.12)
	Jensen Alpha	(1.29)
	Total Risk Alpha	(3.48)
	Treynor Ratio	1.17
	Maximum Drawdown	131.4
	Value At Risk	(4.55)
	Potential Upside	4.76
	Skewness	(4.24)
	Kurtosis	31.88

	Risk Adjusted Performance	(0.07)
	Market Risk Adjusted Performance	1.18
	Mean Deviation	4.52
	Coefficient Of Variation	(925.37)
	Standard Deviation	13.17
	Variance	173.49
	Information Ratio	(0.12)
	Jensen Alpha	(1.29)
	Total Risk Alpha	(3.48)
	Treynor Ratio	1.17
	Maximum Drawdown	131.4
	Value At Risk	(4.55)
	Potential Upside	4.76
	Skewness	(4.24)
	Kurtosis	31.88

Consider Histogen's intraday indicators

Histogen intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Histogen stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.2
	Daily Balance Of Power	(1.35)
	Rate Of Daily Change	0.74
	Day Median Price	0.0226
	Day Typical Price	0.0217
	Market Facilitation Index	0.0051
	Price Action Indicator	(0.01)
	Period Momentum Indicator	(0.01)

Histogen time-series forecasting models is one of many Histogen's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Histogen's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Histogen Stock media impact

Far too much social signal, news, headlines, and media speculation about Histogen that are available to investors today. That information is available publicly through Histogen media outlets and privately through word of mouth or via Histogen internal channels. However, regardless of the origin, that massive amount of Histogen data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Histogen news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Histogen relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Histogen's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Histogen alpha.

Histogen Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Histogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.

Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Histogen Corporate Management

Stephen Hill	VP Controller	Profile
Steven Mento	Interim Chairman	Profile
Thomas Hubka	Director Sec	Profile
Gail Naughton	Founder Advisor	Profile

When determining whether Histogen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Histogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Histogen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Histogen Stock: